Cargando…
ProCOC: The prostate cancer outcomes cohort study
BACKGROUND: Despite intensive research over the last several decades on prostate cancer, many questions particularly those concerning early diagnosis and the choice of optimal treatment for each individual patient, still remain unanswered. The goal of treating patients with localized prostate cancer...
Autores principales: | Umbehr, Martin, Kessler, Thomas M, Sulser, Tullio, Kristiansen, Glen, Probst, Nicole, Steurer, Johann, Bachmann, Lucas M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441625/ https://www.ncbi.nlm.nih.gov/pubmed/18559088 http://dx.doi.org/10.1186/1471-2490-8-9 |
Ejemplares similares
-
The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation
por: Umbehr, Martin H., et al.
Publicado: (2018) -
Systematic quantitative overviews of the literature to determine the value of diagnostic tests for predicting acute appendicitis: study protocol
por: Bachmann, Lucas M, et al.
Publicado: (2002) -
What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors? – Protocol of a systematic review
por: Scharplatz, M, et al.
Publicado: (2004) -
Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial
por: Leitner, Lorenz, et al.
Publicado: (2017) -
The cost-saving effect of continuity of care (COC): an analysis of institutional COC on diabetic treatment costs using panel 2SLS regressions
por: Wen, Yu-Ping, et al.
Publicado: (2021)